Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: TRI

InspectIR Systems Begins COVID-19 Detection Trial

FRISCO, Texas, May 28, 2020 /PRNewswire/ -- InspectIR Systems, LLC, a purpose-driven company with proprietary measurement methods, devices and tools, has begun clinical trials aimed at detecting the novel coronavirus (COVID-19).

InspectIR partnered with University of North Texas Associate Dean of Research, College of Science, Dr. Guido Verbeck and has developed a patent-pending real-time, mobile testing device for the detection of hundreds of volatile organic compounds on the breath, such as illicit drugs.

"As most of us have experienced, the world has changed due the coronavirus pandemic. We challenged our development teams with a simple question: 'Can we help?' We quickly realized our devices could identify COVID-19 in the breath and help with the unique circumstances facing the U.S. and the world right now," said CEO Tim C. Wing. "It provides detection of VOCs on the breath, including COVID-19, Influenza A and more, in as little as 90 seconds. This means health professionals can almost immediately have an accurate diagnosis and begin effectively treating the patient ? giving them a far better chance for a positive outcome."

One of the many challenges of facing the current COVID-19 testing is the frequency of false positives as well as false negatives, which have been reported potentially as high as 48.5%.

COO John Redmond states, "Accuracy has been an issue with COVID-19 testing since the beginning of the crisis. Our device is specifically designed for trace detection in the high part-per-trillion. We believe it will provide the most accurate results on the market. There are few viable non-invasive detection tools available today."

As Dr. Verbeck explains further, "Using a mass spectrometer coupled with the InspectIR patented technology, our device can detect and identify chemical molecules in the breath. That means it can literally smell and identify substances on your breath."

Clinical trials began yesterday, in partnership with Dr. Gustavo Day and his practice at Medical City Dallas. The InspectIR team is excited about what the future holds, as the initial data confirms expectations. The InspectIR portable breathalyzer could be a true game-changer in the battle against COVID-19. InspectIR has begun the FDA "emergency usage authorization" process.

For more information on InspectIR and the COVID-19 detection trial, visit www.inspect-ir.com, email info@inspect-ir.com or follow us on Twitter @inspect_ir.

About InspectIR Systems, LLC

InspectIR is a research, development and device company focused on non-invasive portable detection and measurement tools. InspectIR is a purpose-driven business with a mission and mindset that accountability begins with measurement. Developing proprietary methods and devices, InspectIR provides clients in a variety of fields with the confidence that they are receiving accurate results in real time.

Related Images

InspectIR Systems, LLC
InspectIR Systems begins COVID testing trial.

SOURCE InspectIR Systems

These press releases may also interest you

at 06:15
The "Manufacture of Breakfast Cereals in South Africa 2020" report has been added to ResearchAndMarkets.com's offering. This report focuses on the Manufacture of Breakfast Cereals and includes information on the state of the sector and factors that...

at 06:10
The COVID-19 outbreak has put a damper on business activity across the world. With travel limitations in place across markets, it is difficult for international buyers to travel for visiting physical exhibitions. But there is a simple solution ? go...

at 06:10
Toptal, the world's largest fully remote company, today announced a new consulting service to help organizations build and sustain robust remote work environments. Since its inception in 2010, and today with over 4,000 people working remotely, Toptal...

at 06:05
Global trade fell 14.8% in the second quarter of 2020 according to the latest data from Tradeshift. But evidence of an upward curve in June suggests the impact of the COVID-19 pandemic could bottom out at the lower end of the 13-32% range predicted...

at 06:05
The "E-prescribing Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering. This report predicts the global e-prescribing market to grow with a CAGR of 22.10% over...

at 06:05
SurveyMonkey , a leading global survey software company, today shared findings from two studies of more than 2,000 market research professionals in the U.S. to...

News published on 28 may 2020 at 09:00 and distributed by: